RBC Capital on ADC Therapeutics (ADCT): 'A Critical Year Ahead for Zynlonta Expansion De-Risking'
Go back to RBC Capital on ADC Therapeutics (ADCT): 'A Critical Year Ahead for Zynlonta Expansion De-Risking'| ADC TELECOMM (NYSE: ADCT) | Delayed: 1.10 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.10 | 52 Week High | $12.76 | |||
| Open | $1.10 | 52 Week Low | $5.18 | |||
| Day High | $1.10 | P/E | 1.41 | |||
| Day Low | $1.10 | EPS | $0.78 | |||
| Volume | 1,541 | |||||
